达达提因在小鼠不同大脑区域的N-甲基-D-酸盐受体信号通路中优先升级
Azeez Olakunle Ishola1, Adedeji Enitan Adetunji1, Isaac Chukwunwike Abanum1
1Department of Anatomy, College of Medicine and Health Sciences, Afe Babalola University Ado-Ekiti, Nigeria.
Basic and clinical neuroscience
|June 22, 2023
概括
一次低剂量达米可以增强N-甲基-D-酸盐受体 (NMDAR) 的活性,这表明它具有神经保护的潜力. 这项研究研究了datuetine.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 之前的研究表明,达美丁与N-甲基-D-酸盐受体 (NMDARs) 有结合性亲缘关系.
- 长时间暴露于达图,通过改变NMDAR信号,模仿了谷氨酸毒性.
研究的目的:
- 在BALB/c小鼠中研究一次性低剂量数据的潜在神经保护作用.
- 评估数据对特定大脑区域NMDAR信号通路的影响.
主要方法:
- 三十只雄性BALB/c小鼠被分为三个组:载体,达图梅丁 (0.1毫克/公斤) 和MK-801+达图梅丁 (0.5毫克/公斤MK-801跟着0.1毫克/公斤达图梅丁).
- 通过神经元,vGlut和NMDAR亚型的西部斑块和免疫组织化学 (IHC) 在脑样本中评估了NMDAR信号分子.
主要成果:
- 在海马体和前额叶皮层 (PFC) 中,达图降低了甲基素激酶IIα (CamKIIα) 的下调.
- 在PFC和其他地区观察到循环AMP反应元素结合蛋白 (CREB) 和化CREB (pCREB) 的升级.
- 大脑衍生性神经营养因子 (BDNF) 在达图的管理后在海马体和PFC上调.
- 迪佐西尔平 (MK-801) 部分逆转了达图的作用,没有发现显著的组织学变化.
结论:
- 一次低剂量达特可以适度增强NMDAR活性.
- 这些发现表明低剂量达图暴露的潜在神经保护性质.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
204
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
204


